Monopar Therapeutics Quarterly Liabilities, Current in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
Monopar Therapeutics quarterly Liabilities, Current history and growth rate from Q4 2016 to Q4 2023.
  • Monopar Therapeutics Liabilities, Current for the quarter ending December 31, 2023 was $1.76M, a 43.8% decline year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $1.76M -$1.37M -43.8% Dec 31, 2023 10-K 2024-03-28
Q3 2023 $1.98M +$67.5K +3.53% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $2.5M +$315K +14.4% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $2.89M +$1.81M +169% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $3.13M +$1.55M +98% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $1.91M Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $2.19M Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $1.07M +$268K +33.2% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.58M +$404K +34.3% Dec 31, 2021 10-K 2023-03-23
Q1 2021 $806K +$363K +81.8% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $1.18M +$453K +62.5% Dec 31, 2020 10-Q 2021-05-13
Q3 2020 $610K +$126K +26.1% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $573K +$105K +22.4% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $444K -$136K -23.5% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $724K +$325K +81.2% Dec 31, 2019 10-K 2021-03-25
Q3 2019 $484K +$172K +55.1% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $468K +$145K +44.9% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $580K +$289K +99.6% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $400K +$87.7K +28.1% Dec 31, 2018 10-K 2020-03-27
Q3 2018 $312K Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $323K Jun 30, 2018 10-Q 2018-08-09
Q1 2018 $291K Mar 31, 2018 10-Q 2018-05-11
Q4 2017 $312K +$247K +383% Dec 31, 2017 10-K 2019-02-26
Q4 2016 $64.5K Dec 31, 2016 10-K 2018-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.